Progressive loss of cortical acetylcholinesterase activity in association with cognitive decline in Alzheimer's disease: A positron emission tomography study

Annals of Neurology

Volumn 48, Issue 2, 2000, Pages 194-200

  Shinotoh, Hitoshi ^a,b   Namba, Hiroki ^a   Fukushi, Kiyoshi ^a   Nagatsuka, Shin Ichiro ^a,c   Tanaka, Noriko ^a   Aotsuka, Akiyo ^a,d   Ota, Tsuneyoshi ^a   Tanada, Shuji ^a   Irie, Toshiaki ^a  

^a NATIONAL INSTITUTE OF RADIOLOGICAL SCIENCES   (Japan)

^b Asahi Neurological Hospital   (Japan)

^c DAIICHI PURE CHEMICALS CO LTD   (Japan)

^d CHIBA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINESTERASE;

ADULT; AGED; ALZHEIMER DISEASE; AMYGDALOID NUCLEUS; ARTICLE; CHOLINERGIC SYSTEM; CLINICAL ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME KINETICS; FEMALE; HIPPOCAMPUS; HUMAN; MALE; NEOCORTEX; OLIVARY NUCLEUS; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL;

ACETYLCHOLINESTERASE; AGED; ALZHEIMER DISEASE; ANALYSIS OF VARIANCE; BRAIN MAPPING; CEREBRAL CORTEX; CHOLINERGIC FIBERS; COGNITION DISORDERS; DISEASE PROGRESSION; FEMALE; HUMAN; LONGITUDINAL STUDIES; MALE; MIDDLE AGE; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0033867948     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/1531-8249(200008)48:2<194::AID-ANA9>3.0.CO;2-X     Document Type: Article

References (28)

1. The cholinergic hypothesis of Alzheimer's disease: A review of progress
2. Selective loss of central cholinergic neurons in Alzheimer's disease
3. Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia
4. Alzheimer's disease: Choline acetyltransferase activity in brain tissue from clinical and pathological subgroups
5. Neurochemical characteristics of early and late onset types of Alzheimer's disease
6. Neurochemical correlates of dementia severity in Alzheimer's disease: Relative importance of the cholinergic deficits
7. The neurochemistry of Alzheimer type, vascular type and mixed type dementias compared
8. Cholinergic markers in elderly patients with early signs of Alzheimer disease
9. Brain acetylcholinesterase activity: Validation of a PET tracer in a rat model of Alzheimer's disease
10. Measurement of acetylcholinesterase by positron emission tomography in the brains of healthy controls and patients with Alzheimer's disease
11. Preserved acetylcholinesterase activity in aged human cerebral cortex
12. Human cerebral acetylcholinesterase activity measured with positron emission tomography: Procedure, normal values and effect of age
13. Positron emission tomography measurement of acetylcholinesterase activity reveals differential loss of ascending cholinergic systems in Parkinson's disease and progressive supranuclear palsy
14. In vivo mapping of cerebral acetylcholinesterase activity in aging and Alzheimer's disease
15. 11C]methylpiperidin-4-yl propionate: Alternatives for analysis of an irreversible positron emission tomography tracer for measurement of acetylcholinesterase activity in human brain
16. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease
17. A new clinical scale for the staging of dementia
18. 'Mini-mental state.' A practical method for grading the cognitive state of patients for the clinician
19. Central cholinergic pathways in the rat: An overview based on an alternative nomenclature (Ch1-Ch6)
20. Molecular forms of acetylcholinesterase and butyrylcholinesterase in the aged human central nervous system
21. Overlap between acetylcholinesterase-rich and choline acetyltransferase-positive (cholinergic) axons in human cerebral cortex
22. In vivo mapping of cholinergic terminals in normal aging, Alzheimer's disease, and Parkinson's disease
23. The pedunculopontine nucleus in Parkinson's disease, progressive supranuclear palsy, and Alzheimer's disease
24. Loss of pedunculopontine neurons in progressive supranuclear palsy
25. Cortical biopsy in Alzheimer's disease: Diagnostic accuracy and neurochemical, neuropathological, and cognitive correlation
26. Cholinesterase-like domains in enzymes and structural proteins: Functional and evolutionary relationships and identification of a catalytically essential aspartic acid
27. Cholinergic neurites in senile plaques
28. Anatomy of cholinesterase inhibition in Alzheimer's disease: Effect of physostigmine and tetrahydroaminoacridine on plaques and tangles